Synektik

Synektik Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Synektik (SNT.WA) as of Oct 31, 2026 is 76.06 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 105.88 % — a change of -28.16% (lower).

Cash Conversion

76.06 %

YoY

-28.16%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Synektik is 2025 76.06 % . Cash Conversion Rate (OCF/Net Income) of Synektik was 2024 105.88 % . It decreases by -28.16% lower compared to the previous year.

The Synektik Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
50.76 PLN
Jan 1, 2019
148.28 PLN
Jan 1, 2020
158.09 PLN
Jan 1, 2021
258.96 PLN
Jan 1, 2022
-60.03 PLN
Jan 1, 2023
180.15 PLN
Jan 1, 2024
105.88 PLN
Jan 1, 2025
76.06 PLN
The Synektik Cash Conversion history
YEARCash ConversionYoY
76.06 %-28.16%
105.88 %-41.23%
180.15 %-400.10%
-60.03 %-123.18%
258.96 %+63.80%
158.09 %+6.62%
148.28 %+192.15%
50.76 %-85.77%
356.70 %-117.17%
-2,077.26 %+359.26%
-452.31 %-236.30%
331.84 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

Cash Conversion Rate (OCF/Net Income) of Synektik is 76.06 % in 2025.

Cash Conversion Rate (OCF/Net Income) of Synektik changed from 105.88 % to 76.06 %, representing a -28.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Synektik since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Synektik with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Synektik

All Key Metrics — Synektik